{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:14:39Z","timestamp":1759331679512,"version":"build-2065373602"},"reference-count":105,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.arcmed.2006.09.003","type":"journal-article","created":{"date-parts":[[2007,7,5]],"date-time":"2007-07-05T14:07:41Z","timestamp":1183644461000},"page":"691-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Recurrent Viral Liver Disease (Hepatitis B and C) after Liver Transplantation"],"prefix":"10.1016","volume":"38","author":[{"given":"Marco Antonio","family":"Olivera-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan F.","family":"Gallegos-Orozco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2006.09.003_bib1","first-page":"345","article-title":"Prevention of hepatitis B virus infection after orthotopic liver transplantation","volume":"3","author":"Wang","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.arcmed.2006.09.003_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/lt.20492","article-title":"Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective","volume":"7","author":"Terrault","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.1840130402","article-title":"Orthotopic liver transplantation for patients with hepatitis B virus related liver disease","volume":"13","author":"Todo","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1053\/jhep.2000.19789","article-title":"Hepatitis B immune globulin to prevent hepatitis B virus graft re-infection following liver transplantation: a concise review","volume":"32","author":"Shouval","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7150\/ijms.2.41","article-title":"Management of hepatitis B infection in liver transplantation","volume":"2","author":"Vierling","year":"2005","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.arcmed.2006.09.003_bib6","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/00007890-199605150-00013","article-title":"Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization","volume":"61","author":"McGory","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib7","series-title":"Transplantation of the Liver","first-page":"327","article-title":"Liver transplantation in patients with chronic hepatitis B and C","author":"Rosen","year":"2001"},{"key":"10.1016\/j.arcmed.2006.09.003_bib8","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","article-title":"Liver transplantation in European patients with the hepatitis B surface antigen","volume":"329","author":"Samuel","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2006.09.003_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep.510260232","article-title":"A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis","volume":"2","author":"Naumann","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib10","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/01.tp.0000186919.00303.ec","article-title":"Prevention of hepatitis B recurrence after liver transplantation","volume":"80","author":"Seehofer","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib11","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/00007890-200110270-00008","article-title":"Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation","volume":"78","author":"Seehofer","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/00007890-200110270-00008","article-title":"Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation","volume":"72","author":"Eehofer","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/lt.20217","article-title":"Outcome of liver transplantation for hepatitis B in the United States","volume":"10","author":"Kim","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0168-8278(99)80204-9","article-title":"High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation","volume":"30","author":"Mutimer","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1432-2277.2000.tb01084.x","article-title":"Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation","volume":"13","author":"Seehofer","year":"2000","journal-title":"Transplant Int"},{"key":"10.1016\/j.arcmed.2006.09.003_bib16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0140-6736(96)04444-3","article-title":"Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis","volume":"348","author":"Grellier","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2006.09.003_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/gut.46.1.107","article-title":"Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient","volume":"46","author":"Mutimer","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2006.09.003_bib18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/jhep.2001.21554","article-title":"A multi-center United States-Canadian trial to assess lamividine monotherapy before and after transplantation for chronic hepatitis B","volume":"33","author":"Perrillo","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-0012.2005.00467.x","article-title":"Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy","volume":"20","author":"Nath","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.arcmed.2006.09.003_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jlts.2000.8310","article-title":"Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against post-transplantation hepatitis B","volume":"6","author":"Angus","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib21","first-page":"742","article-title":"Prevention and treatment of hepatitis B virus reinfection after liver transplantation","volume":"44","author":"Lu","year":"2006","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"10.1016\/j.arcmed.2006.09.003_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/lt.20701","article-title":"Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B immune globulin prophylaxis","volume":"12","author":"Zheng","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib23","first-page":"1419","article-title":"Adefovir dipivoxil therapy for lamivudine resistant hepatitis B in pre- and post-liver transplantation patients","volume":"38","author":"Schiff","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0016-5085(03)00939-9","article-title":"Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase","volume":"125","author":"Angus","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib25","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1016\/j.transproceed.2005.10.061","article-title":"Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine resistant Hepatitis B virus","volume":"37","author":"B\u00e1rcena","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/lt.20416","article-title":"Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine","volume":"11","author":"Lo","year":"2005","journal-title":"Liver Transplant"},{"key":"10.1016\/j.arcmed.2006.09.003_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cld.2004.02.012","article-title":"Antiviral therapy: nucleoside and nucleotide analogues","volume":"8","author":"Quan","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.arcmed.2006.09.003_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1517\/13543784.12.4.683","article-title":"Entecavir: A potent new antiviral drug for hepatitis B","volume":"12","author":"Honkoop","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.arcmed.2006.09.003_bib29","first-page":"619A","article-title":"Entecavir reduces viral load in liver transplant patients who have failed prophylaxis or treatment for hepatitis B","volume":"34","author":"Shakil","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-0711-5-8","article-title":"Prevention and treatment of recurrent hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues","volume":"5","author":"Schreibam","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.arcmed.2006.09.003_bib31","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1345\/aph.1E280","article-title":"Tenofovir therapy for lamivudine resistance following liver transplantation","volume":"38","author":"Neff","year":"2004","journal-title":"Ann Pharmco-Therapy"},{"key":"10.1016\/j.arcmed.2006.09.003_bib32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/hep.1840380407","article-title":"Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease","volume":"38","author":"Bienzle","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/hep.510310233","article-title":"Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation","volume":"31","author":"S\u00e1nchez-Fueyo","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/01.TP.0000113804.35096.8E","article-title":"Adoptive transfer of immunity: a new strategy to interfere with severe hepatitis virus re-infection after woodchuck liver transplantation","volume":"77","author":"Dahmen","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature04083","article-title":"Hepatitis C and liver transplantation","volume":"436","author":"Brown","year":"2005","journal-title":"Nature"},{"issue":"Suppl 2","key":"10.1016\/j.arcmed.2006.09.003_bib36","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/S1542-3565(05)00709-3","article-title":"Treatment of recurrent hepatitis C in liver transplant recipients","volume":"3","author":"Terrault","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/lt.20424","article-title":"Management of hepatitis C virus infection in the setting of liver transplantation","volume":"11","author":"Rodriguez-Luna","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-2006-947298","article-title":"Viral hepatitis and liver transplantation","volume":"26","author":"Sharma","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.arcmed.2006.09.003_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/lt.500060111","article-title":"Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: persistent elevation of serum transaminase levels versus necroinflammatory activity","volume":"6","author":"Pelletier","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/jhep.2000.9408","article-title":"Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate","volume":"32","author":"Pelletier","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(00)80231-7","article-title":"HCV-related fibrosis progression following liver transplantation: increase in recent years","volume":"32","author":"Berenguer","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib42","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/lt.20238","article-title":"One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection","volume":"10","author":"Firpi","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib43","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1478-3231.2005.01120.x","article-title":"Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis","volume":"25","author":"Saab","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2006.09.003_bib44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib45","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/jlts.2003.50268","article-title":"Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C","volume":"9","author":"Wiesner","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib46","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jhep.2004.06.029","article-title":"Fibrosis progression after liver transplantation in patients with recurrent hepatitis C","volume":"41","author":"Neumann","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/jhep.2002.33993","article-title":"Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients","volume":"36","author":"Berenguer","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib48","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gut.51.2.248","article-title":"Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C","volume":"51","author":"Wali","year":"2002","journal-title":"Gut"},{"issue":"Suppl 2","key":"10.1016\/j.arcmed.2006.09.003_bib49","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/lt.20597","article-title":"Recurrence of hepatitis C infection: where are we now?","volume":"11","author":"Charlton","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/lt.20344","article-title":"Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation","volume":"11","author":"Samonakis","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib51","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1053\/j.gastro.2005.11.013","article-title":"HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation","volume":"130","author":"Belli","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib52","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.transproceed.2004.12.169","article-title":"DR antigens influence graft outcome and HCV recurrence after liver transplantation","volume":"37","author":"Kimball","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib53","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.tp.0000173645.89064.c7","article-title":"Platelet-derived growth factor gene polymorphism in recurrent hepatitis C infection after liver transplantation","volume":"81","author":"Ben-Ari","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/lt.20583","article-title":"Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome","volume":"12","author":"Watt","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib55","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/lt.20455","article-title":"Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation","volume":"11","author":"Gawrieh","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib56","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/jlts.2001.29414","article-title":"Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation","volume":"7","author":"Nelson","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib57","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/01.TP.0000088668.28950.7C","article-title":"Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation","volume":"76","author":"Chopra","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/jlts.2002.32282","article-title":"Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C","volume":"8","author":"Burak","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib59","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.transproceed.2004.11.005","article-title":"The long-term effects of immune suppression on liver transplant recipients with recurrent hepatitis C viral infection","volume":"36","author":"Neff","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib60","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.transproceed.2005.02.103","article-title":"Retrospective analysis of the impact of immunosuppression on the course of recurrent hepatitis C after liver transplantation","volume":"37","author":"Bahr","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib61","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3748\/wjg.v12.i5.697","article-title":"Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis","volume":"12","author":"Hilgard","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib62","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/lt.20222","article-title":"Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial","volume":"10","author":"Martin","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib63","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.transproceed.2004.11.041","article-title":"Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease","volume":"37","author":"Inoue","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/lt.20532","article-title":"Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation","volume":"12","author":"Firpi","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2003.11.080","article-title":"Specific inhibition of hepatitis C virus replication by cyclosporin A","volume":"313","author":"Nakagawa","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2006.09.003_bib66","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/lt.20453","article-title":"Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C","volume":"11","author":"Wiesner","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/jlts.2002.29763","article-title":"A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C","volume":"8","author":"Jain","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib68","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-6143.2004.00706.x","article-title":"MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: impact on histological course","volume":"5","author":"Bahra","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.arcmed.2006.09.003_bib69","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/01.TP.0000140881.07208.4E","article-title":"Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine","volume":"78","author":"Filipponi","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib70","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.transproceed.2004.12.153","article-title":"Preliminary analysis of early outcomes of a prospective, randomized trial of complete steroid avoidance in liver transplantation","volume":"37","author":"Pelletier","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib71","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.transproceed.2004.12.042","article-title":"Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study","volume":"37","author":"Kato","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib72","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.tp.0000181192.13836.8c","article-title":"Induction with rabbit antithymocyte globulin versus induction with corticosteroids in liver transplantation: impact on recurrent hepatitis C virus infection","volume":"81","author":"Nair","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib73","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jhep.2005.12.010","article-title":"Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study","volume":"44","author":"Llado","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib74","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2005.11.047","article-title":"Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence","volume":"44","author":"Tisone","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib75","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2006.01.005","article-title":"Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression","volume":"44","author":"Berenguer","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib76","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0168-8278(03)00310-6","article-title":"Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation","volume":"39","author":"Forns","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib77","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/hep.20793","article-title":"Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy","volume":"42","author":"Everson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib78","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.transproceed.2005.02.041","article-title":"Effectiveness of pegylated interferon and ribavirin in patients with liver HCV cirrhosis","volume":"37","author":"Moreno Planas","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib79","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arcmed.2006.09.003_bib80","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2006.09.003_bib81","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2006.09.003_bib82","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/lt.20405","article-title":"A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients","volume":"11","author":"Davis","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib83","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/JVI.80.6.2654-2664.2006","article-title":"Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients","volume":"80","author":"Eren","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib84","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0041-1345(00)02508-2","article-title":"Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment","volume":"33","author":"Mazzaferro","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2005.02.015","article-title":"Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation","volume":"43","author":"Castells","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib86","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.transproceed.2005.09.018","article-title":"Preemptive therapy with pegylated interferon alpha-2b and ribavirin after liver transplantation for hepatitis C cirrhosis","volume":"37","author":"Castedal","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib87","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.20560","article-title":"Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials","volume":"41","author":"Chalasani","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib88","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.TP.0000100481.14514.BB","article-title":"Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series","volume":"77","author":"Rodriguez-Luna","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib89","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/01.TP.0000129811.93072.1C","article-title":"Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy","volume":"78","author":"Neff","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib90","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.TP.0000149499.78996.B3","article-title":"Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C","volume":"79","author":"Bizollon","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib91","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.transproceed.2005.03.124","article-title":"Peginterferon and ribavirin in patients with HCV cirrhosis after liver transplantation","volume":"37","author":"Moreno Planas","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib92","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1155\/2005\/745197","article-title":"Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: from a Canadian experience to recommendations for therapy","volume":"19","author":"Babatin","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib93","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1478-3231.2005.1065.x","article-title":"Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation","volume":"25","author":"Yedibela","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2006.09.003_bib94","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.transproceed.2005.10.060","article-title":"Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients","volume":"37","author":"Oton","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib95","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1016\/j.transproceed.2005.10.018","article-title":"Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation","volume":"37","author":"Mukherjee","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.arcmed.2006.09.003_bib96","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.dld.2005.08.009","article-title":"Pegylated interferon plus ribavirin for recurrent hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen","volume":"38","author":"Biselli","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.arcmed.2006.09.003_bib97","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1600-6143.2006.01255.x","article-title":"Pegylated interferon alpha-2b for patients with HCV recurrence and graft fibrosis following liver transplantation","volume":"6","author":"Heydtmann","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.arcmed.2006.09.003_bib98","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/j.1600-6143.2005.00976.x","article-title":"Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C","volume":"5","author":"Bizollon","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.arcmed.2006.09.003_bib99","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/hep.20947","article-title":"Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors","volume":"42","author":"Schiano","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.09.003_bib100","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/01.TP.0000142677.12473.E5","article-title":"Preemptive therapy for hepatitis C virus after living-donor liver transplantation","volume":"78","author":"Sugawara","year":"2004","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2006.09.003_bib101","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1053\/jlts.2002.35861","article-title":"Retransplantation for recurrent hepatitis C","volume":"8","author":"Ghobrial","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib102","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/lt.20301","article-title":"Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection","volume":"10","author":"Neff","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.arcmed.2006.09.003_bib103","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1542-3565(05)00158-8","article-title":"Liver retransplantation for hepatitis C virus recurrence: a survey of liver transplant programs in the United States","volume":"3","author":"Burton","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2006.09.003_bib104","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00007890-199812270-00007","article-title":"Hepatitis C infection in patients undergoing liver retransplantation","volume":"66","author":"Rosen","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.09.003_bib105","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/lt.20517","article-title":"Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome","volume":"11","author":"Carmiel-Haggai","year":"2005","journal-title":"Liver Transpl"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440906003110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440906003110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:35:45Z","timestamp":1759260945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440906003110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":105,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0188440906003110"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2006.09.003","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent Viral Liver Disease (Hepatitis B and C) after Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2006.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}